Back to Search
ROBERT NICHOLSON, MD
MD
Family Medicine Physician
NPI: 1245291566IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
43745(MN)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2000
Research & Publications (20)
Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance.
PMID 19288272·Breast Cancer Res Treat·2010
8-other
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.
PMID 19238537·Breast Cancer Res Treat·2010
8-other
Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells.
PMID 18493848·Breast Cancer Res Treat·2009
8-other
Expression of a phosphorylated p130(Cas) substrate domain attenuates the phosphatidylinositol 3-kinase/Akt survival pathway in tamoxifen resistant breast cancer cells.
PMID 19330798·J Cell Biochem·2009
8-other
Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activation.
PMID 19246244·Trends Mol Med·2009
8-other
Control of microbial contamination of Franz diffusion cell receptor phase in the development of transcutaneous breast cancer therapeutics.
PMID 19674294·Lett Appl Microbiol·2009
7-preclinical
Doubly diastereoselective conjugate addition of homochiral lithium amides to homochiral alpha,beta-unsaturated esters containing cis- and trans-dioxolane units.
PMID 19194592·Org Biomol Chem·2009
8-other
MyD88 and TRIF mediate the cyclic adenosine monophosphate (cAMP) induced corticotropin releasing hormone (CRH) expression in JEG3 choriocarcinoma cell line.
PMID 19615077·Reprod Biol Endocrinol·2009
8-other
Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival.
PMID 18825690·J Pathol·2009
8-other
Doubly diastereoselective [3,3]-sigmatropic aza-Claisen rearrangements.
PMID 19503936·Org Biomol Chem·2009
8-other
Unintended effects of emphasizing disparities in cancer communication to African-Americans.
PMID 18990735·Cancer Epidemiol Biomarkers Prev·2008
2-rct
Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
PMID 19074892·Cancer Res·2008
8-other
Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells.
PMID 19055788·Breast Cancer Res·2008
8-other
The cannabinoid receptor agonist CP-55,940 and ethyl arachidonate interfere with [(3)H]batrachotoxinin A 20 alpha-benzoate binding to sodium channels and inhibit sodium channel function.
PMID 18599378·Comp Biochem Physiol C Toxicol Pharmacol·2008
7-preclinical
New approaches to understanding double-stranded RNA processing by ribonuclease III purification and assays of homodimeric and heterodimeric forms of RNase III from bacterial extremophiles and mesophiles.
PMID 19161841·Methods Enzymol·2008
8-other
Highly (E)-selective Wadsworth-Emmons reactions promoted by methylmagnesium bromide.
PMID 18975957·Org Lett·2008
8-other
Lipopolysaccharide stimulation of trophoblasts induces corticotropin-releasing hormone expression through MyD88.
PMID 18771998·Am J Obstet Gynecol·2008
8-other
In vitro effects on MCF-7 breast cancer cells of signal transduction inhibitor/tamoxifen/eicosapentaenoic acid combinations and their simultaneous delivery across skin.
PMID 18622691·Pharm Res·2008
7-preclinical
SRC as a therapeutic target in breast cancer.
PMID 19075780·Endocr Metab Immune Disord Drug Targets·2008
6-review
Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen.
PMID 19005469·Nature·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1601 SAINT FRANCIS AVE
SHAKOPEE, MN 55379 - Phone
- (952) 428-3535
Quick Facts
- NPI
- 1245291566
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile